-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ofaMtvNZ-5KdhWAJjXfZpN
February 01, 2011 - who reported sometimes or never using sun-
screen. … : reference
Sometimes use: 1.1 (0.8–1.4)
Regular use: 1.8 (1.2–2.7)
Total lifetime use
Never: reference … use: reference
Sometimes use: 1.5 (1.1–2.2)
Never use: 2.1 (1.5–3.0)
NR Age, history of sunburn, skin … : reference
Sometimes use: 1.3 (0.9–1.9)
Almost always use: 1.8 (1.1–2.8)
NR Age, sex, region, history … : reference
Sometimes use: 1.3 (0.9–1.9)
Always initially and sometimes use: 0.9 (0.6–1.5)
Always use
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2023-12/health-equity-framework-report.pdf
January 01, 2023 - meta-regression or visual
inspection of plots as methods for investigating potential effect modification is usually … The comparator or reference group should always be
specified (e.g., whole population, White population … Results should always be stratified by study design with consideration of
stratification of results … evidence may be important to communicate to patients and clinicians, differences in
epidemiology alone usually … • Only use “diverse” to mean “everyone,” never simply “people who aren’t White.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-adults-screening-and-counseling-2003
December 15, 2003 - In selected patients, surgery promotes large amounts of weight loss with rare but sometimes severe complications … sibutramine-induced weight loss. 32 , 33 , 84 , 86 , 87 , 105 Orlistat generally, 90 , 96 , 106-109 but not always … 84 , 86 , 87 , 112 , 113 improvement in 3 others. 32 , 114 , 115 Orlistat was frequently (but not always … Prospective study of intentional weight loss and mortality in never-smoking overweight US white women
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/nmcMhEwWT9BncBBBQQN6Uf
December 01, 2015 - Benefits will always fall short of the projected results since access and use is not universal. … In
addition, depending on the nature of the scenario, it is sometimes possible to impose
parallelism … Actual benefits will always fall short of the
projected results since use and access is not perfect. … These analyses start with populations of women who are alive and have never developed breast cancer … Other sources of variation are related to assumptions about the proportions
of DCIS cases that never
-
www.uspreventiveservicestaskforce.org/Home/GetFile/1/16255/collabmodelingbc/pdf
December 01, 2015 - Benefits will always fall short of the projected results since access and use is not universal. … In
addition, depending on the nature of the scenario, it is sometimes possible to impose
parallelism … Actual benefits will always fall short of the
projected results since use and access is not perfect. … These analyses start with populations of women who are alive and have never developed breast cancer … Other sources of variation are related to assumptions about the proportions
of DCIS cases that never